Ask AI

Expert Guidance on Therapy Selection for Advanced NSCLC: First-line Therapy and Beyond

The Interactive Decision Support Tool and the associated text module allow clinicians to benefit from expert recommendations for specific advanced NSCLC case scenarios and the accompanying series of 6 tightly focused concise expert-authored ClinicalThought commentaries will allow clinicians to better understand the rapid changes happening in this area.

Share

Program Content

No activities added yet

No activities added yet

Supporters

This activity is supported by educational grants from

Boehringer Ingelheim

Genentech BioOncology

Lilly

Novartis Oncology